chrisvoncsefalvay/vaers-outcomes huggingface dataset:
same rash in the arm in the same spot in addition of one or more rashes on other parts of her body; a few rashes on her head and torso and in the injection site a large rash started hurting again; hurting rash around the injection site; soreness on her arm; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on her arm), VACCINATION SITE RASH (hurting rash around the injection site), RASH (a few rashes on her head and torso and in the injection site a large rash started hurting again), RASH (same rash in the arm in the same spot in addition of one or more rashes on other parts of her body) and PYREXIA (fever) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013792002 and 012m20a) for COVID-19 vaccination.     Concomitant products included RIVAROXABAN (XARELTO) and SIMVASTATIN (SIMVASTATINE) for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness on her arm) and PYREXIA (fever). On 07-Mar-2021, the patient experienced VACCINATION SITE RASH (hurting rash around the injection site). On 05-Aug-2021, the patient experienced RASH (a few rashes on her head and torso and in the injection site a large rash started hurting again). On 16-Aug-2021, the patient experienced RASH (same rash in the arm in the same spot in addition of one or more rashes on other parts of her body). On 27-Feb-2021, PAIN IN EXTREMITY (soreness on her arm) and PYREXIA (fever) had resolved. On 10-Mar-2021, VACCINATION SITE RASH (hurting rash around the injection site) had resolved. On 08-Aug-2021, RASH (a few rashes on her head and torso and in the injection site a large rash started hurting again) had resolved. At the time of the report, RASH (same rash in the arm in the same spot in addition of one or more rashes on other parts of her body) had not resolved.            Treatment information was not provided. The next day after her 2nd dose patient experienced a fever and soreness on her arm which lasted a day. On the 11th day after her 2nd dose patient experienced a hurting rash around the injection site which lasted 4 days. 2 weeks ago patient started to experience a few rashes on her head and torso and in the injection site a large rash started hurting again for 4 days. Patient still has a few rashes which are large and not very itchy in other parts of her body. 3 days ago, patient experienced the same rash in the arm in the same spot in addition of one or more rashes on other parts of her body.
Around 7:30 pm, arm started hurting.  started having itching of neck and face.  Took Benadryl around that time. felt hot.  patient would get a cold rag.  developed a headache and had some nausea.  around 12:30 am, vomited 3x and then at 5am vomited again.  noticed swelling around her eyes and lip.  noticed a red rash on her arms. came to the the office today with her daughter.  and decided to be seen.  has had Benadryl again.  on exam now.  no swelling of lips noted.  reddish rash on arms.  slight swelling around left eye lid.
This case was reported by a nurse via sales rep and described the occurrence of injection site rash in a adult female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX (subcutaneous). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site rash, injection site pain, injection site swelling, injection site erythema and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site rash, injection site pain, injection site swelling and injection site erythema were recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown. The reporter considered the injection site rash, injection site pain, injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The patient was administered SHINGRIX on the left arm subcutaneously rather than intramuscularly, which led to incorrect route of vaccination. The patient also experienced a rash which was red, swollen and painful at the injection site as bad reaction. The side effects had resolved but no additional details was available. The clinic claimed that they reported this adverse event information but the sales representative said that she discovered on the reporting date that they did not report it to the proper channels.
I went to the restroom during the middle of the night at 2:00 am. I passed out coming back to the bed, hit the ground, and had a seizure. My wife witnessed the event.
it puffed out; it was really swollen; redness has spread down to her elbow; there's like a hardness to it; fever; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness). At the time of the report, SKIN SWELLING (it puffed out), SWELLING (it was really swollen), ERYTHEMA (redness has spread down to her elbow), INDURATION (there's like a hardness to it), PYREXIA (fever) and FATIGUE (tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.
This afternoon, my left arm began to hurt around the site of my injection. The pain progressively began to increase and around seven PM it hurt to move my arm.  The muscles in my upper arm twitch occasionally. Pain is localized around the upper arm and radiates only until my elbow. Movement makes it worse. There is slight swelling around the area of injection.
Heard female 89 years old received 2nd does of Moderna and platelet levels rapidly declining. The doctor wanted to give a transfusion and patient went home to conder.
The day after the second dose, headache and body ache. These side effects lasted only a day.  Numbness and tingling on the left side of my lower lip and left side of my tongue.  This side effect is ongoing.
Shortly after the injection the patient complained of some mild discomfort and on the Monday following the injection being given on a Friday, she called the office concerned about itching and swelling at the injection site as well as pain.  She was advised to apply topical triamcinolone for itching and take a dose of benadryl 25 mg in addition to her daily cetirizine.  She was subsequently seen for persistent pain and found to have a small focus of fluid that was seen at base of fat layer in upper arm and not intramuscular on ultrasound.  she was referred to physical therapy for further treatment to improve the motion in her upper arm.
Swollen rt arm; Temp 102F; Red & hot; Not using arm @ all; Seen by MD on 7MAR poss cellulitis; Rx: Keflix;
Left arm swollen, hot and painful now after pneumococcal vaccine yesterday. Swelling and heat goes to scapula and ear lobe. She has used TYLENOL and symptoms are worsening. pain is 7/10 now as injection site. She denies wheezing. Patient will go to ER now at this nurse's recommendation. No provider in clinic. 05/09/2013 call placed back to patient now. She never went to ER. She states she had a fever and then it left over night. Slight rash remains at injection site. There are 2 linear rashes 1 inch a part and fading. Patient states she took TYLENOL and stayed home. Patient called triage nurse last evening through her HMO and they recommended ice and to stay home from work and to continue to take TYLENOL. She is just watching the rash per now as directed by HMO nurse.
illness onset 1 day post vaccine (headache, fever, chills, aches) Severe body rash and Prurtus appearing over multiply locations on the torso, back, head, legs and arms approximately 2 weeks after second (2nd) Moderna vaccination shot. Other symptoms include headache, fatigue, dizziness, asthenia,  Current course of treatment prescribed for rash is Prednisone 20mg.  Symptoms as yet NOT resolved.
04/09/04 Mother placed a call to me on 04/09/04 at 9am, descrIbing an "allergic reaction" to a vaccine that child received on 04/07/04.  The child was taken to the emergency room on the evening of 04/08/04 with "red, swollen left arm from should to elbow."  No c/o pain from child.  ER tx included inst for mother to give Benadryl and Motrin following OTC inst.  Mother was instructed by ER physician to see PCP  today (04/09/04).
Developed 3.5"x4" redness, swelling and tenderness at injection site 72 hours post injection.
Menstrual cycle was later than usual and flow was light. Normal menstrual cycle last 5-7 days with 2-3 heavy days at the beginning of menstruation followed by medium and light days. My menstruation was nearly 2 weeks late and lasted 1 (medium flow) day with light random light spotting.
We gave the wrong vaccine to a patient. lt was the Gardasil 9 vaccine and this patient is 50 years old .; This practice manager reported that a 50 year old female patient received the Gardasil 9 vaccine instead of the Hepatitis B vaccine; This spontaneous report was received from a practice manager and refers to a 50-year-old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 30-NOV-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot# 1621934, expiration date 29-JAN-2022 (dose and route of administration were not reported). The reporter stated that the patient received the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) instead of hepatitis b vaccine (manufacturer unknown) (product administered to patient of inappropriate age and wrong product administered). combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1621934; expirationdate: 29-JAN-2022; deviceage and unit: 0 ; operatorofdevice: Unknown; malfunction: Unknown; deviceusage: Unknown; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Rash on both thighs @ inject site, later devel knot smaller than pea; says afebrile, denies other sx; 2JAN92 no further problems; planning to continue w/vax series;
Urgent frequent urination; 100 degree fever; This is a spontaneous report received from a contactable consumer (patient) via COVID-19 Adverse Event Self-Reporting Solution. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27Mar2021 at 14:00 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was not allergic to food, medication or any other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 27Mar2021 at 14:00, the patient experienced urgent frequent urination. This was elaborated as sometimes so urgent, that was unable to make it to a bathroom, even at home. The patient also experienced 100-degree fever. Immediately upon receiving the shot, felt the need to urinate when there was no need to prior. On 27Mar2021 at 14:00, the patient underwent body temperature measurement and the result was 100-degree fever. The patient was not treated with any medication for the events. The adverse events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of urgent frequent urination and 100-degree fever was not resolved.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Received first COVID-19 vaccine Friday 1/8/21 - experienced an episode of palpitations, chest tightness w/ sob, hypertension, and headache - it subsided that night. Had 2 similar episodes since that time. Seen in ED 1/11/21 for symptoms. Similar episode occured after receiving the Flu vaccine about 3 years ago.
Received boostrix instead of Infanrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 6-year-old patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Previously administered products included DTPA (last series of DTAP).   On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: Received boostrix instead of Infanrix).  The outcome of the wrong vaccine administered was unknown.   Additional Information: GSK receipt date: 07-SEP-2023 The health care professional (HCP) did not have any other details and would call back with more information. They were on the last series of DTAP. The patient accidently received  Boostrix instead of Infanrix, which led to wrong vaccine administered  The reporter consented to follow up The case is linked with US2023122482, by same reporter.; Sender's Comments:  US-GSK-US2023122482:Same reporter
MODERN 0.5 ML FOR IM                                                                                                           LOT 020B21A EPX:09/23/2021                                                                                                 No known adverse events.
Roughly 3 months after receiving J&J I was admitted into the ER with severe chest pains. I had inflamed arteries suggesting a pulmonary embolism. After many tests they suggested myocarditis. It cleared up in about 4 days (received blood thinners at the ER & took 1000mg ibuprofen for 7 days). I believe that this wasn't more harmful to me as I am in great health. I was also on a estrogen birth control for about 5 years. I also received 2 rounds of the HPV vaccine within the past 12 months. It's hard to assume what could have caused this but wanted to share my experience
Nausea, Vomiting, Fever, Muscle Cramps, Weakness, Shivering.
Local reaction, erythema, edema, tenderness (mild), fever headache within 24 hrs of administration.
No adverse event; 18-year-old patient received Monovalent 6-11 Booster only Moderna COVID-19 vaccine instead of Bivalent booster on 31MAR2023; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (18-year-old patient received Monovalent 6-11 Booster only Moderna COVID-19 vaccine instead of Bivalent booster on 31MAR2023) and NO ADVERSE EVENT (No adverse event) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018C22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1), PFIZER BIONTECH COVID-19 VACCINE (1st booster dose) and PFIZER BIONTECH COVID-19 VACCINE (Dose 2). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 31-Mar-2023, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG PRODUCT ADMINISTERED (18-year-old patient received Monovalent 6-11 Booster only Moderna COVID-19 vaccine instead of Bivalent booster on 31MAR2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (18-year-old patient received Monovalent 6-11 Booster only Moderna COVID-19 vaccine instead of Bivalent booster on 31MAR2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (18-year-old patient received Monovalent 6-11 Booster only Moderna COVID-19 vaccine instead of Bivalent booster on 31MAR2023).    No concomitant medications were reported.     No treatment medications were reported.
After vaccination, patient was fine. He sat down for observation. 5 minutes passed and I heard  "SOMEONE HELP". Patient was tensing up and unresponsive (looked like a mini-seizure). Patient peed on himself and after 3-4 seconds patient was fully responsive. Patient stated he was fine and didn't know what happened. Patient did not want me to call an ambulance and person with him told me not to call. We waited a little longer, patient complained of feeling really hot. He laid down on the floor and I gave him some water and a lollipop to increase sugar levels. After 3-5 minutes patient sat down on the chair and stated he was feeling much better. After a few minutes, he complained of wanting to vomit. As soon as I was able to give him a bag, he violently threw up. Patient stated that he was now feeling much better. He went to the bathroom and cleaned up. After a little longer observation, patient said he was fine and wanted to go home. They left. I called patient an hour later and he stated he felt fine and was just resting. Will follow up with patient tomorrow.
"Excruciating" pain at injection site x weeks. Patient was unable to do her sport. Onset 10/5/16, No treatment. Pt did not return to office for care.
Sore arm; Headache; Upset stomach; Chest pain; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 32030BD) via an unspecified route of administration in the left arm on 12Nov2021 at 11:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration in the left arm on 22Oct2021 at 11:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 13Nov2021 at 09:00, the patient experienced sore arm, headache, upset stomach and chest pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, headache, upset stomach and chest pain was resolved with sequelae on unknown date in Nov2021.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The pharmacist noted that the patient was administered the first two doses in the GARDASIL vaccination schedule "2 years ago" and that the third dose of GARDASIL (intramuscularly, Lot#, dose/frequency were unspecified) would be administered today (28-AUG-2012). No adverse effect reported. It was unspecified whether the patient had sought medical attention or not. No treatment information was reported. The outcome was unknown. Additional information has been requested.
pt recv vax & immed p/vax devel red & raised areas over the sites;denied itching;denied SOB;no signs of resp distress;chest area inspected;red, raised area above rt nipple;denied itching;no other areas noted;given DPH by mouth p/consulting
Are of 4cm diameter at injection site with 10cm horizontal line to trunk, mildly raised, mildly tender, afebrile. Area was circled with a pen to assistant parent in monitoring area, ibuprofen was also recommended pain/discomfort.
axillary adenopathy, fever , chills, flank pain, desaturation of oxygen , lethargy
Patient was observed post Covid-19 immunization for 15 minutes .  During the observation period, she experienced an adverse reaction with the following symptoms:  dizziness.   Assessment : Time of assessment 1023. Alert and oriented. Patient says as soon as she received her vaccine and sat down for her 15 minute observation, she started feeling like she was going to pass out, feeling dizzy. She was taken to the triage area via w/c, BP 85/39, P 51, then 88/35 P 49. She was not in any distress, no sweating, alert and answering questions. 1026: EMS called. 1028: BP 99/50, P 52, c/o headache, drinking water. 1034: BP 106/46, P 50; 1043: BP 96/47, P 56, EMS arrived at 1045.   Actions taken:  Vitals sign taken  EMS called at  1026. VAERS form obtained and completed by RN. Hand off to EMS upon arrival at 1045.   Medications administered: No medication administered.   Disposition:Patient evaluated and transferred to the hospital for further evaluation and care. Time of transport: 1055.
The Moderna Bivalent vaccine was administered after a temperature excursion and the vaccine was not viable.
2 out of 7 patients returned w/i 24 hrs w/ reaction described as "local,reddened area of 3-4 inches in diameter-red,hot,swollen, & oozing."Both pts were given antibiotics & diphenhydramine.The phys. are concerned w/ having a bad batch.
Had not taken any new medication or anything new - Woke up on Friday with a rash which turned it whelps all over.  extreme itching.  Went to Medsurg clinic to be seen.  The doctor ask if I had taken the Covid vaccine and what date.  The MD felt like that is what has caused the rash.   Rash occurred on day 9 after the vaccine.   Rash was treated with steriods, antihistamines, pepcid, and Atarax for the itching.   Rash is almost gone in 4 days.
photo-allergic drug reaction on tops of feet and ankles after stepping outside into sun. This has happened to me in the past after 3 different drugs. I went to the ER because I was worried this reaction would be very severe. The ER advised benedryl and to stay out the sun for 1 week, and to come back in if the reaction continues to spread.  In the past the blisters have turned in to scars, and the skin will loose pigmentation.